Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
TVM Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
TVM Capital

TVM Capital

Operating

TVM Capital Life Science is a global venture capital firm specializing in multi-stage investments in life science sectors.

Location
Munich, Bavaria, DE
Founded
1995
Firm
Compare
Portfolio
Employees
Website

Investments

Egg Medical
Egg Medical

Total Raised

$16.1M

Rounds

4

Series Unknown$13MMarch 2022
Access Vascular
Access Vascular

Total Raised

$57.1M

Rounds

7

Series B$20MMarch 2021
Rapid Micro Biosystems
Rapid Micro Biosystems
Public

Total Raised

$377.4M

Rounds

12

Series C$25MApril 2015
Series Unknown$6MApril 2014
Series B$32.6MJune 2013
Series A$18.6MAugust 2009
bluebird bio
bluebird bio
Public

Total Raised

$3.4B

Rounds

17

Series D$60MJuly 2012
Series C$30MApril 2011
Series B$35MMarch 2010
Anchor Therapeutics
Anchor Therapeutics
Acquired

Total Raised

$29M

Rounds

2

Series B$10MAugust 2010
Helomics
Helomics

Total Raised

$211.5M

Rounds

11

Series D$33MJune 2010
Series Unknown$20MMarch 2006
Series B$17.5MNovember 2001
Arteris
Arteris
Public

Total Raised

$52M

Rounds

7

Series D$9.7MDecember 2009
Series C$7.5MMay 2008
Series B$8.1MJune 2007
Ubidyne
Ubidyne
Acquired

Total Raised

$58.5M

Rounds

2

Series B$43MAugust 2009
Series A$15.5MSeptember 2005
BitWave Semiconductor
BitWave Semiconductor

Total Raised

$27.6M

Rounds

4

Series B$10MAugust 2008
Series A$13MJanuary 2004
Ascent Therapeutics
Ascent Therapeutics

Total Raised

$19M

Rounds

1

Series A$19MNovember 2007
RenaMed Biologics
RenaMed Biologics

Total Raised

$40M

Rounds

1

Series Unknown$40MSeptember 2006
Impress Software
Impress Software

Total Raised

$36.9M

Rounds

3

Series C$10MSeptember 2005
Series B$7.6MOctober 2004
Amnis
Amnis
Acquired

Total Raised

$21.9M

Rounds

4

Series C$11.3MAugust 2005